⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

June 17, 2005Journal of Cardiovascular Pharmacology

Blocking Characteristics of hKv1.5 and hKv4.3/hKChIP2.2 After Administration of the Novel Antiarrhythmic Compound AZD7009

View Full Paper

Ask AI

Bookmark

Share

Authors

FPFrida PerssonOnderstepoort Veterinary Academic Hospital LCLeif CarlssonAstraZeneca (United States)GDGöran DukerAstraZeneca (Sweden)

Discussion

Loading...

Member takes

Implication

May guide atrial-selective antiarrhythmic development; leaves open clinical efficacy and safety in AF.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Persson et al. (2005) studied this question.

synapsesocial.com/papers/6a8590aa90c4f21ff9d5abbc https://doi.org/10.1097/01.fjc.0000161405.37198.c1

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Dihydropyridine Ca2+ channel antagonists and agonists block Kv4.2, Kv4.3 and Kv1.4 K+ channels expressed in HEK293 cells2003 · 39 citations
2Effects of propafenone on K currents in human atrial myocytes1999 · 28 citations
3Potential Molecular Basis of Different Physiological Properties of the Transient Outward K<sup>+</sup>Current in Rabbit and Human Atrial Myocytes1999 · 202 citations
4Extracellular Acidosis Modulates Drug Block of Kv4.3 Currents by Flecainide and Quinidine2003 · 19 citations
5Identity of a novel delayed rectifier current from human heart with a cloned K+ channel current.1993 · 353 citations